Curation SCA12 PPP2R2B
7 + 1.5 = 8.5 / 18
Genetic evidence
Total: 7
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | SCA12 is described as relatively frequent in a northern Indian endogamous community due to a founder effect, caused by PPP2R2B repeat expansion, rare outside India, and characterized initially by coarse action tremor with later cerebellar signs. | |
Collective Evidence | Allele | 1 | PPP2R2B SCA12 is listed as an autosomal dominant promoter CAG repeat expansion disorder with proposed gain-of-function/polyalanine and RAN-translation mechanisms; this is locus-specific but not primary allele-size correlation data. |
Experimental evidence
Total: 1.5
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Biochemical function | 0.5 | Gene-level evidence: PPP2R2B encodes brain-specific PP2A-PR55β, a regulatory subunit of protein phosphatase PP2A; PP2A is implicated in cell-cycle progression, tau phosphorylation, and apoptosis. Not SCA12-repeat-specific functional proof. | |
Function | Protein interaction | 0.5 | Gene-level evidence: PR55β/PPP2R2B is described as a regulatory subunit of the trimeric PP2A holoenzyme. This supports pathway context but is not a direct SCA12 repeat-expansion protein-interaction assay. | |
Function | Regulatory impact | 0.5 | Locus-specific regulatory context: the SCA12 CAG repeat lies in the 5′ region/putative 5′ UTR near PPP2R2B transcription-start and promoter elements; patient lymphoblastoid cells had no detectable PPP2R2B RNA or protein, so direct regulatory impact was not demonstrated in disease-relevant tissue. |